Update: BIO-Europe growing further
Europe’s largest partnering event, the BIO-Europe, hit another visitor record on the occasion of its 25th anniversary in Hamburg.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1118 entries already.
Entries by Thomas Gabrielczyk
Magenta Therapeutics exercises ATAC licence option
/in News/by Thomas GabrielczykMagenta Therapeutics has exercised the option to licence Heidelberg Pharma AGs anti-CD45-Antibody Targeted Amanitin Conjugate (ATAC).
SciRhom targets autoimmunity switch
/in News/by Thomas GabrielczykAutoimmunity specialist SciRhom GmbH has kicked of a first-in-class antibody development programme targeting iRhom2.
AMR: ENABLE selects Mutabilis candidate
/in News/by Thomas GabrielczykA drug combo breaking antibiotic resistance of Gram-negative priority pathogens has been selected under the ENABLE programme of the Innovative Medicines Initiative (IMI).
NSCLC: Bemcentinib + anti-PD1 triple PFS
/in News/by Thomas GabrielczykBergen Bio ASAs Axl kinase blocker bemcentinib in combination with MSDs pembrolizumab has met the primary endpoint in a Phase II study in patients with non small cell lung cancer […]
Transposase makes CAR-T production cheaper
/in News/by Thomas GabrielczykGerman researchers have designed a modified Sleeping Beauty transposase that can be used for non-viral, stable and efficient gene insertions for gene and CAR-T therapies.
Test detects breast cancer in earliest stage
/in News/by Thomas GabrielczykBreast cancer might be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced […]
Sherlock Bioscience and Mologic enter partnership
/in News/by Thomas GabrielczykSynbio specialist Sherlock Biosciences and next-generation lateral flow testing expert Mologic Ltd have joined forces to develop a no-instrument rapid testing platform detecting virtually every infectious pathogen in low resource […]
Protein protects against liver fibrosis
/in News/by Thomas GabrielczykGerman researchers have shown that a protein protects against the development of liver fibrosis by shutting down inflammatory signalling in liver stellate cells of the liver.
bit bio restarts with new management
/in News/by Thomas GabrielczykCell reprogramming specialist bit bio has expanded its management with renowned experts in the field.